Document is current
Any future updates will be listed below
-
Authors
Sadjadi, Mahan
Marcello, Matteo
Drammeh, Miles
Booke, Hendrik
Hognon-Bak, Katarzyna
Aistleitner, Lisa
Schöne, Ludwig Maximilian
Strauß, Christian
Mertes, Moritz J.
Zarbock, Alexander
-
Funding
Funding for this research was provided by:
Universitätsklinikum Münster
- License Information
-
More Information
Article History
Received: 12 February 2026
Accepted: 7 May 2026
First Online: 28 May 2026
Change Date: 28 July 2026
Change Type: Update
Change Details: The statement of Acknowledgements has been updated.
Declarations
Ethics approval and consent to participate: Ethics approval was obtained from the Research Ethics Committee of the Chamber of Physicians, Westfalen-Lippe, and the University of Münster (2023–180-f-S) Written informed consent was obtained from all participants.
Consent for publication: Not applicable.
Competing interests: Alexander Zarbock has received consulting fees from Astute-Biomerieux, Baxter, Bayer, Novartis, Guard Therapeutics, AM Pharma, Paion, and Fresenius, research funding from Astute-Biomerieux, Fresenius, and Baxter, and speaker fees from Astute-Biomerieux, Fresenius, and Baxter. All other authors have no competing interests to declare.
